Molecular Biology Enzymes, Reagents, And Kits Market To Reach $34.11 Billion By 2033

July 2025 | Report Format: Electronic (PDF)

Molecular Biology Enzymes, Reagents And Kits Market Growth & Trends

The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 34.11 billion by 2033, registering a CAGR of 9.99% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina’s NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.


key Request a free sample copy or view the report summary: Molecular Biology Enzymes, Reagents, and Kits Market Report


Molecular Biology Enzymes, Reagents And Kits Market Report Highlights

  • By product, the kits and reagents held the largest share in 2024. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth

  • By application, sequencing accounted for the largest share in 2024 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth

  • By end-use, the pharma and biotech segment held the largest share in 2024. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth

  • North America held the largest revenue share in 2024. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

Molecular Biology Enzymes, Reagents, and Kits Market Segmentation

Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market report based on product, application, end use, and region:

Molecular Biology Enzymes, Reagents And Kits Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Kits & Reagents

    • PCR Kits

    • qPCR Kits

    • RT-PCR Kits

    • Library Preparation Kits

    • Cloning Kits

    • Purification Kits

    • Gene Editing Kits

    • Other Kits

  • Enzymes

    • Polymerases

      • DNA Polymerases

        • High Fidelity DNA Polymerases

          • Pfu DNA Polymerases

          • Phusion DNA Polymerases

          • Hot Start DNA Polymerases

          • Taq DNA Polymerases High Fidelity

          • Others

        • Thermostable DNA Polymerases

          • Standard Taq DNA Polymerases

          • Tth DNA Polymerases

          • Others

        • Strand-displacing DNA Polymerases

          • Bst DNA Polymerases

          • Phi29 DNA Polymerases

          • Others

      • RNA Polymerases

        • T7 RNA Polymerase

        • SP6 RNA Polymerase

        • T3 RNA Polymerase

        • Other RNA Polymerase

    • Reverse Transcriptase (RTs)

      • M-MLV RT

      • AMV RT

      • Thermostable RT

      • Template Switch

      • TGIRT

      • Induro

      • MarathonRT

    • Ligases

      • DNA Ligases

        • T4 DNA Ligases

        • E coli DNA Ligase

        • Taq DNA Ligase

        • Others

      • RNA Ligases

    • Nucleases

      • DNase I

      • RNase A, RNase H

      • Nickases

      • Restriction Nucleases

      • TdTs

    • Endonucleases

      • EndoQ

      • AP Nuclease

  • Kinases

  • Phosphatases

  • CRISPR-associated Enzymes

    • Cas9

    • Cas12a (Cpf1)

    • Cas13

  • Specialty Enzymes

  • Others

Molecular Biology Enzymes, Reagents And Kits Application Outlook (Revenue, USD Million, 2021 - 2033) 

  • Cloning

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Sequencing

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • PCR

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Epigenetics

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Genotyping

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • RCA/MDA

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • RNA Therapeutics

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Transcriptomics

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Proteomics

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others 

  • Liquid Biopsy

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others

  • Other Applications

    • Pharma & Biotech

      • Research

      • Therapeutics/Production

    • Academic & Research

    • Hospital & Diagnostics

    • Others

Molecular Biology Enzymes, Reagents And Kits End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharma & Biotech

    • Research

    • Therapeutics/Production

  • Academic & Research

  • Hospital & Diagnostics

  • Others

Molecular Biology Enzymes, Reagents And Kits Regional Outlook (Revenue, USD Million, 2021 - 2033) 

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players of Molecular Biology Enzymes, Reagents And Kits Market

  • Thermo Fisher Scientific, Inc.

  • Illumina, Inc.

  • Agilent Technologies, Inc.

  • QIAGEN

  • Promega Corporation

  • New England Biolabs

  • Merck KGaA

  • F. Hoffmann-La Roche Ltd.

  • Bio-Rad Laboratories, Inc.

  • Takara Bio, Inc.

  • LGC Limited

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization